Diffuse Lung Disease: Diffuse Lung Disease: Interstitial Lung Disease |

Mice Alveolar Epithelial Cells Phenotype Changed by NMDA Receptors Activation FREE TO VIEW

Yang Li, PhD; Fei-Yan Zhao; Wei Liu; Yan-Hong Huang; Chen Li; Dan-Dan Feng; Jian-Zhong Han; Zi-Qiang Luo
Author and Funding Information

Central South University, Changsha, China

Copyright 2016, American College of Chest Physicians. All Rights Reserved.

Chest. 2016;149(4_S):A216. doi:10.1016/j.chest.2016.02.223
Text Size: A A A
Published online

SESSION TITLE: Diffuse Lung Disease: Interstitial Lung Disease

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM

PURPOSE: Pulmonary fibrosis is a sever disease which threaten human health, with progressing myofibroblast proliferation, extracellular matrix accumulation. Epithelial-mesenchymal transition (EMT) is an important resource of myofibroblast in pulmonary fibrosis. We had found that NMDA receptors participated in bleomycin induced acute lung injury. We aimed to find out whether NMDA receptors activation contributes to EMT.

METHODS: MLE-12 cells are divided into teo groups: Con, NMDA and harvested 48h after NMDA or TGFβ1 stimulation. Mesenchymal cell marker α-SMA and alveolar epithelial cell markers SP-C, E-cadherin expression and phosphorylation of MAPK signal pathway were detected by Real-time qPCR and/or western blot.

RESULTS: NMDA receptors were expressed on MLE-12, mice alveolar epithelial cell line by RT-PCR and western blot. After 10mM NMDA stimulation α-SMA mRNA expression (P<0.01) and protein expression trend were increased, the trend of SP-C mRNA expression were decreased (P=0.1) and E-Cadherin protein expression were decreased (P<0.05) in MLE-12. The phosphorylation levels of MAPKs were increased, including ERK, JNK, p38 protein.

CONCLUSIONS: 10mM NMDA can induce EMT and MAPKs phosphorylation in MLE-12. NMDA receptors activation promote EMT may be involved in MAPKs phosphorylation.

CLINICAL IMPLICATIONS: NMDA receptors may play an important role in treatment of pulmonary fibrosis.

DISCLOSURE: The following authors have nothing to disclose: Yang Li, Fei-Yan Zhao, Wei Liu, Yan-Hong Huang, Chen Li, Dan-Dan Feng, Jian-Zhong Han, Zi-Qiang Luo

No Product/Research Disclosure Information




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543